These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21914461)

  • 41. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases.
    Grey A; Banovic T; Naot D; Hill B; Callon K; Reid I; Cornish J
    Endocrinology; 2001 Mar; 142(3):1098-106. PubMed ID: 11181524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual regulation of actin rearrangement through lysophosphatidic acid receptor in neuroblast cell lines: actin depolymerization by Ca(2+)-alpha-actinin and polymerization by rho.
    Fukushima N; Ishii I; Habara Y; Allen CB; Chun J
    Mol Biol Cell; 2002 Aug; 13(8):2692-705. PubMed ID: 12181339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
    Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
    Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Essential role for G proteins in prostate cancer cell growth and signaling.
    Kue PF; Daaka Y
    J Urol; 2000 Dec; 164(6):2162-7. PubMed ID: 11061948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential FAK phosphorylation at Ser-910, Ser-843 and Tyr-397 induced by angiotensin II, LPA and EGF in intestinal epithelial cells.
    Jiang X; Sinnett-Smith J; Rozengurt E
    Cell Signal; 2007 May; 19(5):1000-10. PubMed ID: 17240116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms.
    Lin CI; Chen CN; Huang MT; Lee SJ; Lin CH; Chang CC; Lee H
    Cell Signal; 2008 Oct; 20(10):1804-14. PubMed ID: 18627789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
    Olianas MC; Dedoni S; Onali P
    Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin II stimulates rat astrocyte mitogen-activated protein kinase activity and growth through EGF and PDGF receptor transactivation.
    Clark MA; Gonzalez N
    Regul Pept; 2007 Dec; 144(1-3):115-22. PubMed ID: 17688958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An integrated phosphoproteomics work flow reveals extensive network regulation in early lysophosphatidic acid signaling.
    Schreiber TB; Mäusbacher N; Kéri G; Cox J; Daub H
    Mol Cell Proteomics; 2010 Jun; 9(6):1047-62. PubMed ID: 20071362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eicosopentaneoic Acid and Other Free Fatty Acid Receptor Agonists Inhibit Lysophosphatidic Acid- and Epidermal Growth Factor-Induced Proliferation of Human Breast Cancer Cells.
    Hopkins MM; Zhang Z; Liu Z; Meier KE
    J Clin Med; 2016 Jan; 5(2):. PubMed ID: 26821052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visualization of the binding between gintonin, a
    Choi SH; Lee RM; Cho HS; Hwang SH; Hwang HI; Rhim H; Kim HC; Kim DG; Cho IH; Nah SY
    J Ginseng Res; 2022 May; 46(3):348-356. PubMed ID: 35600777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lysophosphatidic acid in airway function and disease.
    Toews ML; Ediger TL; Romberger DJ; Rennard SI
    Biochim Biophys Acta; 2002 May; 1582(1-3):240-50. PubMed ID: 12069834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The LPA
    Solís KH; Romero-Ávila MT; Guzmán-Silva A; García-Sáinz JA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lysophosphatidic Acid and Ion Channels as Molecular Mediators of Pain.
    Juárez-Contreras R; Rosenbaum T; Morales-Lázaro SL
    Front Mol Neurosci; 2018; 11():462. PubMed ID: 30618613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LPA
    Solís KH; Romero-Ávila MT; Rincón-Heredia R; García-Sáinz JA
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?
    Duflot T; Tu L; Leuillier M; Messaoudi H; Groussard D; Feugray G; Azhar S; Thuillet R; Bauer F; Humbert M; Richard V; Guignabert C; Bellien J
    Metabolites; 2021 Nov; 11(11):. PubMed ID: 34822442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Regulation of Lysophosphatidic Acid Receptor 1 Maturation and Desensitization.
    Zhao J; Stephens T; Zhao Y
    Cell Biochem Biophys; 2021 Sep; 79(3):477-483. PubMed ID: 34032994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Landscape of GPCR expression along the mouse nephron.
    Poll BG; Chen L; Chou CL; Raghuram V; Knepper MA
    Am J Physiol Renal Physiol; 2021 Jul; 321(1):F50-F68. PubMed ID: 34029142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.
    Xu Y
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31658655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lysophosphatidic Acid Signaling in Diabetic Nephropathy.
    Lee JH; Kim D; Oh YS; Jun HS
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.